U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07284121) titled 'A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice' on Nov. 21.

Brief Summary: This is a non-interventional, multi-country, multi-centre, multicohort, primary data collection study, designed to assess patients' reported satisfaction with Atezolizumab Subcutenous (SC) treatment and Health-related Quality of Life (HRQoL), as well as the effectiveness and safety of Atezolizumab SC in participants treated for selected approved indications in routine clinical practice.

Study Start Date: July 17

Study Type: OBSERVATIONAL

Condition: Lung Canc...